Status:

COMPLETED

Cortex Motor Function Reorganization in Stroke Patients

Lead Sponsor:

Guangzhou General Hospital of Guangzhou Military Command

Conditions:

Ischemic Stroke

Eligibility:

All Genders

18-75 years

Brief Summary

In China, stroke is among the highest morbidity and mortality, especially in senile population. Most of those patients had survived with various degrees of cerebral dysfunction; among them about 50% w...

Detailed Description

The cases derive from patients with acute ischemic stroke hospitalized in Neurology Department General Hospital of Guangzhou Military Command of PLA. The diagnosis of ischemic stroke is diagnosed usin...

Eligibility Criteria

Inclusion

  • The first onset, the lesion was the single lesion of infarction or hemorrhage confirmed by head Magnetic Resonance Imaging(MRI) or Computed Tomography(CT).
  • Hemiplegic hand muscle strength above grade 3, and was able to cooperate with the stimulation task of f MRI examination.
  • According to the Edinburgh Handedness Questionnaire (EHQ) as the right hand.
  • According to the commonly used eye chart examination, the naked eye vision \>4.9.
  • There is no central nervous system organic disease and other motor diseases that can affect hand function.
  • No previous long-term alcoholism and long-term use of central nervous system activity and other drugs treatment.
  • No contraindication to MRI scan.
  • The patient cooperated with the examination and the patient or their guardian signed an informed consent.

Exclusion

  • Previous diseases of the central nervous system and peripheral nervous system that significantly affected the motor function of limbs.
  • Significant cognitive impairment, MMSE≤27.
  • Subjects was engaged in professional music playing or keyboard operation before illness.
  • The level of consciousness drops after the illness.
  • Significant anxiety and depression status (Hamilton anxiety scale ≥14 points, Hamilton depression scale ≥13 points) and other mental illness and history.
  • Aphasia and neglect.
  • History of epilepsy
  • History of drug dependence
  • Liver dysfunction, renal dysfunction, heart failure or other important organ function loss compensation
  • Contraindication to MRI scan.
  • Refuse to provide written consent or fail to cooperate with inspection for other reasons.

Key Trial Info

Start Date :

January 12 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 30 2020

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT04794673

Start Date

January 12 2020

End Date

August 30 2020

Last Update

March 12 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

General Hospital of Southern Theatre Command,PLA

Guangzhou, Guangdong, China, 510010